companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2014
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -16,250 and a net result of DKK 39,300,875 compared with DKK 7,177,105 the year before. Equity amounted to DKK 66,501,731. The solvency ratio was 100%.
- Gross Profit
- -16,250 kr.
- Profit/Loss
- 39,300,875 kr.
- Equity
- 66,501,731 kr.
- Total Assets
- 66,517,981 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -16 t. | 39.3 mio. | 66.5 mio. | - |
| 2013 | - | -90 t. | 7.2 mio. | 27.2 mio. | - |
| 2012 | - | - | 15.4 mio. | 20 mio. | - |
Keep an eye on NORDIC BIOTECH PRIVATE INVESTORS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of December 11, 2014, is registered as an owner of NORDIC BIOTECH PRIVATE INVESTORS ApS with an ownership share of 15%.
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2013. Gross profit came to DKK -90,481, and the net result was DKK 7,177,105.
As of June 20, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH PRIVATE INVESTORS ApS.
As of June 20, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH PRIVATE INVESTORS ApS.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.